QCi Q2 2026 Earnings: Revenue Growth Has Yet to Produce Gross Profit
Quantum Computing Inc. (QUBT) reported Q2 2026 revenue of $5.6 million, significantly exceeding the prior year's $61 thousand. Despite this growth, the firm posted a $23 million operating loss as costs of revenue and acquisition-related expenses surged. Net loss narrowed to $11.8 million, primarily bolstered by increased interest income and reduced derivative valuation losses rather than core operational improvements. While the company is expanding its photonics and quantum portfolios, key risks include persistent negative gross margins, intensive integration of recent acquisitions, and high cash burn rates from ongoing capital deployment.
Quantum Computing Inc. (Nasdaq: QUBT), or QCi, reported Q2 2026 revenue of $5.6 million for the three months ended June 30, up from $61 thousand a year earlier, while basic and diluted loss per share narrowed to $0.05 from $0.26. Revenue expanded from a small base, but cost of revenue exceeded sales and operating expenses more than doubled, leaving a $23.0 million operating loss. Higher interest income and a smaller derivative valuation loss narrowed the net loss, while recent acquisitions reduced cash and investments to approximately $1.3 billion.
Core Financial Results
Revenue increased across QCi’s portfolio and also rose from $3.7 million in Q1 2026. Management said photonics products were the primary revenue driver, serving aerospace, government, industrial, educational, and commercial customers.
The higher sales did not produce gross profit. Cost of revenue reached $6.7 million, exceeding revenue by approximately $1.2 million. Operating expenses rose 114%, reflecting higher headcount and payroll costs for research and development, sales and marketing spending, and $7.3 million of acquisition-related transaction expenses.
| Metric | Q2 2026 | Q2 2025 | Year-over-year change |
|---|---|---|---|
| Revenue | $5.551 million | $0.061 million | About 91 times the prior-year level |
| Gross profit (loss) | -$1.166 million | $0.026 million | Shifted to a gross loss |
| Gross margin | Approx. -21.0% | Approx. 42.6% | Down approximately 63.6 percentage points |
| Operating expenses | $21.847 million | $10.197 million | Up 114% |
| Operating loss | -$23.013 million | -$10.171 million | Loss widened approximately 126% |
| Interest and other income | $12.954 million | $1.843 million | About 7 times the prior-year level |
| Net loss | -$11.753 million | -$36.482 million | Loss narrowed 67.8% |
| Diluted EPS | -$0.05 | -$0.26 | Loss per share narrowed approximately 80.8% |
Revenue Drivers and Commercial Progress
Photonics products accounted for most of the quarter’s revenue growth. QCi said these products support its quantum roadmap while also addressing existing aerospace, government, and industrial applications.
Several commercial and manufacturing developments accompanied the revenue increase:
- QCi sold, delivered, and installed a Dirac-3 quantum optimization system at a global consulting firm for enterprise optimization applications.
- The company brought its NeuraWave photonic reservoir computing platform to deployment readiness. Its framework agreement with Planck Dynamics supports deployment of up to multiple dozens of systems and has potential aggregate value above $10 million, subject to customer milestones and other conditions.
- QCi received a purchase order from a university for a quantum-secure communications system, although the order value was not disclosed.
- The company completed its acquisition of NHanced Semiconductors for $73.1 million in cash and QCi stock, with up to another $72.0 million contingent on performance targets. The acquisition launched Fab 2 and expanded QCi’s advanced packaging and semiconductor manufacturing capabilities.
Contract backlog was approximately $42.5 million as of June 30, 2026. The timing and conditions attached to individual programs will determine how quickly that backlog and the NeuraWave framework contribute to reported revenue.
Liquidity and Balance Sheet
QCi ended the quarter with approximately $1.3 billion in cash, cash equivalents, and investments, down from approximately $1.5 billion at the end of 2025. The June balance consisted of $189.2 million in cash and cash equivalents, $765.0 million in short-term investments, and $369.3 million in long-term investments.
The company used approximately $180 million in cash, including transaction expenses, for the acquisitions of Luminar Semiconductor, NuCrypt, and NHanced Semiconductors. Total assets nevertheless remained relatively stable at $1.64 billion compared with $1.62 billion at year-end.
Total liabilities increased to $47.2 million from $20.7 million, while stockholders’ equity was $1.59 billion. The large investment portfolio also generated $13.0 million of interest and other income during the quarter, providing a significant offset to operating losses.
A Narrower Net Loss Came From Below the Operating Line
The reduction in QCi’s net loss did not reflect an improvement in operating profitability. Operating loss widened by approximately $12.8 million because the increase in revenue was outweighed by the gross loss and higher operating expenses.
Instead, the main improvement occurred below the operating line. The noncash fair-value loss on the warrant derivative liability declined to $1.7 million from $28.1 million, an improvement of approximately $26.4 million. Interest and other income also increased by approximately $11.1 million. Together, these factors more than offset the larger operating loss and explain why the reported net loss narrowed sharply despite weaker operating profitability.
Recent Insider Transactions
The supplied six-month insider summary classified 618,721 shares across nine transactions as purchases and 78,262 shares in one transaction as sales, resulting in net purchases of 540,459 shares. It reported total insider holdings of 26.93 million shares and net purchases equal to 2.00% of those holdings. Because eight of the latest 10 detailed entries were stock awards, the summary should not be treated as equivalent to open-market buying.
All 10 transactions below were reported as direct holdings. The values are those reported in the supplied insider dataset.
| Date | Insider and role | Reported transaction | Reported value |
|---|---|---|---|
| May 28, 2026 | Yuping Huang, CEO | Stock award at $0.00 per share | $0 |
| May 28, 2026 | Pouya Dianat, Officer | Stock award at $0.00 per share | $0 |
| May 28, 2026 | Milan Begliarbekov, COO | Stock award at $0.00 per share | $0 |
| April 13, 2026 | Michael C. Turmelle, Director | Stock award at $6.78 per share | $149,994 |
| April 13, 2026 | Robert B. Fagenson, Director | Stock award at $6.78 per share | $149,994 |
| April 13, 2026 | Carl Scott Weimer, Director | Stock award at $6.78 per share | $149,994 |
| April 13, 2026 | Javad Shabani, Director | Stock award at $6.78 per share | $149,994 |
| April 13, 2026 | Eric Mark Schwartz, Director | Stock award at $6.78 per share | $149,994 |
| March 11, 2026 | Christopher Bruce Roberts, General Counsel | Sale at $7.85 per share | $614,499 |
| March 10, 2026 | Christopher Bruce Roberts, General Counsel | Derivative security exercise conversion at $6.85 per share | $2.740 million |
Risks Investors Should Watch
- Negative gross margin: Cost of revenue was approximately 121% of revenue, resulting in a gross margin of about negative 21%. Future revenue growth will need to be accompanied by better cost economics to improve operating results.
- High operating expenses and acquisition integration: Operating expenses more than doubled, including $7.3 million of acquisition-related transaction costs. QCi must also integrate three acquisitions completed during the year and translate their capabilities into commercial output.
- Conditional commercialization opportunities: The Planck Dynamics framework depends on specified customer milestones and other conditions. Backlog and potential program value therefore should not be viewed as revenue already recognized.
- Bottom-line volatility from nonoperating items: Changes in the fair value of the warrant derivative liability had a major effect on year-over-year net loss. This noncash item can make reported net income move differently from operating performance.
- Continued use of balance-sheet resources: Cash and investments declined by approximately $200 million from year-end as QCi funded acquisitions, while liabilities increased by $26.5 million. Future manufacturing expansion and acquisition integration will determine the pace of further capital deployment.
Summary
QCi’s second quarter showed a meaningful increase in commercial revenue and progress in photonics products, quantum systems, and semiconductor manufacturing. However, revenue growth did not yet translate into gross or operating profit, and the narrower net loss was driven mainly by higher interest income and a much smaller derivative valuation loss. The main areas to monitor are gross-margin improvement, operating expense trends after the acquisitions, conversion of backlog and conditional agreements into revenue, and the pace of cash deployment.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.